Dorota Gil

1.6k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Dorota Gil is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Dorota Gil has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Dorota Gil's work include Wnt/β-catenin signaling in development and cancer (6 papers), Cellular Mechanics and Interactions (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Dorota Gil is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (6 papers), Cellular Mechanics and Interactions (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Dorota Gil collaborates with scholars based in Poland, United States and Switzerland. Dorota Gil's co-authors include Piotr Laidler, Małgorzata Lekka, Z. Stachura, Janusz Lekki, Α.Z. Hrynkiewicz, Dorota Ciołczyk-Wierzbicka, Joanna Dulińska-Litewka, Krzysztof Okoń, Szymon Prauzner-Bechcicki and Olesya Klymenko and has published in prestigious journals such as International Journal of Molecular Sciences, Archives of Biochemistry and Biophysics and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Dorota Gil

26 papers receiving 1.2k citations

Hit Papers

Elasticity of normal and cancerous human bladder cells st... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers

Dorota Gil
Peter Kim United States
Fang Kong China
Atom Sarkar United States
Ewa P. Wojcikiewicz United States
Simon J. Attwood United Kingdom
Eleanor Kable Australia
Jennifer Lamb United States
Peter Kim United States
Dorota Gil
Citations per year, relative to Dorota Gil Dorota Gil (= 1×) peers Peter Kim

Countries citing papers authored by Dorota Gil

Since Specialization
Citations

This map shows the geographic impact of Dorota Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorota Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorota Gil more than expected).

Fields of papers citing papers by Dorota Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorota Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorota Gil. The network helps show where Dorota Gil may publish in the future.

Co-authorship network of co-authors of Dorota Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Dorota Gil. A scholar is included among the top collaborators of Dorota Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorota Gil. Dorota Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotula‐Balak, Małgorzata, et al.. (2024). The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer. Human Cell. 37(3). 801–816. 6 indexed citations
2.
Gil, Dorota, Marta Zarzycka, Joanna Pabijan, Małgorzata Lekka, & Joanna Dulińska-Litewka. (2023). Dual targeting of melanoma translation by MNK/eIF4E and PI3K/mTOR inhibitors. Cellular Signalling. 109. 110742–110742. 2 indexed citations
3.
Gil, Dorota, Piotr Laidler, Marta Zarzycka, & Joanna Dulińska-Litewka. (2021). Inhibition Effect of Chloroquine and Integrin-Linked Kinase Knockdown on Translation in Melanoma Cells. International Journal of Molecular Sciences. 22(7). 3682–3682. 7 indexed citations
4.
Lekka, Małgorzata, Joanna Zemła, Grażyna Pyka‐Fościak, et al.. (2020). Probing the recognition specificity of αβ integrin and syndecan-4 using force spectroscopy. Micron. 137. 102888–102888. 6 indexed citations
5.
Dulińska-Litewka, Joanna, et al.. (2020). Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?. Medical Oncology. 37(3). 17–17. 6 indexed citations
6.
Gil, Dorota, Marta Zarzycka, Dorota Ciołczyk-Wierzbicka, & Piotr Laidler. (2020). Integrin linked kinase regulates endosomal recycling of N-cadherin in melanoma cells. Cellular Signalling. 72. 109642–109642. 10 indexed citations
7.
Gil, Dorota, Marta Zarzycka, Joanna Dulińska-Litewka, et al.. (2019). Dihydrotestosterone increases the risk of bladder cancer in men. Human Cell. 32(3). 379–389. 17 indexed citations
8.
Ciołczyk-Wierzbicka, Dorota, Dorota Gil, Marta Zarzycka, & Piotr Laidler. (2019). mTOR inhibitor everolimus reduces invasiveness of melanoma cells. Human Cell. 33(1). 88–97. 19 indexed citations
9.
Ciołczyk-Wierzbicka, Dorota, Marta Zarzycka, Dorota Gil, & Piotr Laidler. (2019). mTOR inhibitor Everolimus-induced apoptosis in melanoma cells. Journal of Cell Communication and Signaling. 13(3). 357–368. 14 indexed citations
10.
Ciołczyk-Wierzbicka, Dorota, Dorota Gil, & Piotr Laidler. (2017). Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors. Medical Oncology. 35(1). 7–7. 18 indexed citations
11.
Gil, Dorota, Dorota Ciołczyk-Wierzbicka, Joanna Dulińska-Litewka, & Piotr Laidler. (2016). Integrin-linked kinase regulates cadherin switch in bladder cancer. Tumor Biology. 37(11). 15185–15191. 19 indexed citations
12.
Lekka, Małgorzata, Dorota Gil, Katarzyna Pogoda, et al.. (2011). Cancer cell detection in tissue sections using AFM. Archives of Biochemistry and Biophysics. 518(2). 151–156. 276 indexed citations
13.
Lekka, Małgorzata, Dorota Gil, W Dabroś, et al.. (2011). Characterization of N‐cadherin unbinding properties in non‐malignant (HCV29) and malignant (T24) bladder cells. Journal of Molecular Recognition. 24(5). 833–842. 14 indexed citations
14.
Gil, Dorota, et al.. (2010). The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). Advances in Enzyme Regulation. 51(1). 195–207. 42 indexed citations
15.
Bodzioch, Marek, A. Dembińska-Kieć, J. Hartwich, et al.. (2005). The Microarray Expression Analysis Identifies BAX as a Mediator of β-Carotene Effects on Apoptosis. Nutrition and Cancer. 51(2). 226–235. 9 indexed citations
16.
Gil, Dorota, J. Hartwich, Marek Bodzioch, et al.. (2005). Different effect of beta-carotene on proliferation of prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1740(2). 189–201. 29 indexed citations
17.
Laidler, Piotr, et al.. (2004). From gene to protein: Prostatic acid phosphatase: Structure and expression of gene and protein*. Biochemistry and Molecular Biology Education. 32(6). 400–409. 1 indexed citations
18.
Placha, Wojciech, et al.. (2003). The effect of PPAR?? ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Research. 13(5). 447–456. 35 indexed citations
19.
Lityń́ska, Anna, et al.. (2001). Comparison of the lectin-binding pattern in different human melanoma cell lines. Melanoma Research. 11(3). 205–212. 43 indexed citations
20.
Lekka, Małgorzata, Piotr Laidler, Dorota Gil, et al.. (1999). Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. European Biophysics Journal. 28(4). 312–316. 567 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026